KENDALL WEINERT: Open Payments
NPI 1629030309 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,214 in 53 payments from 16 companies in 2025. Trend: 2023 $555 · 2024 $726 · 2025 $1,214
Food & beverage: $1,214
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $173 |
| Fresenius USA Marketing, Inc. | 12 | $166 |
| Otsuka America Pharmaceutical, Inc. | 8 | $166 |
| Boston Scientific Corporation | 2 | $145 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $83 |
| Novartis Pharmaceuticals Corporation | 2 | $61 |
| ANI Pharmaceuticals, Inc. | 2 | $58 |
| AKEBIA THERAPEUTICS INC | 2 | $50 |
| Ardelyx, Inc. | 2 | $46 |
Products named: TAVNEOS, VELPHORO, JYNARQUE, JARDIANCE, Kerendia, General - EP, WATCHMAN FLX, Fabhalta.
Industry payments across VA — which companies pay providers there.
